Show simple item record

dc.contributor.authorGurramkonda, Chandrasekhar
dc.contributor.authorAdnan, Ahmad
dc.contributor.authorGäbel, Thomas
dc.contributor.authorLünsdorf, Heinrich
dc.contributor.authorRoss, Anton
dc.contributor.authorNemani, Satish K
dc.contributor.authorSwaminathan, Sathyamangalam
dc.contributor.authorKhanna, Navin
dc.contributor.authorRinas, Ursula
dc.date.accessioned2017-01-27T11:53:19Z
dc.date.available2017-01-27T11:53:19Z
dc.date.issued2009-02-10en
dc.identifier.citationMicrobial Cell Factories. 2009 Feb 10;8(1):13en
dc.identifier.urihttp://dx.doi.org/10.1186/1475-2859-8-13en
dc.identifier.urihttp://hdl.handle.net/10033/620790
dc.description.abstractAbstract Background Hepatitis B is a serious global public health concern. Though a safe and efficacious recombinant vaccine is available, its use in several resource-poor countries is limited by cost. We have investigated the production of Hepatitis B virus surface antigen (HBsAg) using the yeast Pichia pastoris GS115 by inserting the HBsAg gene into the alcohol oxidase 1 locus. Results Large-scale production was optimized by developing a simple fed-batch process leading to enhanced product titers. Cells were first grown rapidly to high-cell density in a batch process using a simple defined medium with low salt and high glycerol concentrations. Induction of recombinant product synthesis was carried out using rather drastic conditions, namely through the addition of methanol to a final concentration of 6 g L-1. This methanol concentration was kept constant for the remainder of the cultivation through continuous methanol feeding based on the on-line signal of a flame ionization detector employed as methanol analyzer in the off-gas stream. Using this robust feeding protocol, maximum concentrations of ~7 grams HBsAg per liter culture broth were obtained. The amount of soluble HBsAg, competent for assembly into characteristic virus-like particles (VLPs), an attribute critical to its immunogenicity and efficacy as a hepatitis B vaccine, reached 2.3 grams per liter of culture broth. Conclusion In comparison to the highest yields reported so far, our simple cultivation process resulted in an ~7 fold enhancement in total HBsAg production with more than 30% of soluble protein competent for assembly into VLPs. This work opens up the possibility of significantly reducing the cost of vaccine production with implications for expanding hepatitis B vaccination in resource-poor countries.
dc.titleSimple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigenen
dc.typeJournal Articleen
dc.language.rfc3066enen
dc.rights.holderGurramkonda et al.en
dc.date.updated2015-09-04T08:25:50Zen
refterms.dateFOA2018-06-12T22:08:21Z
html.description.abstractAbstract Background Hepatitis B is a serious global public health concern. Though a safe and efficacious recombinant vaccine is available, its use in several resource-poor countries is limited by cost. We have investigated the production of Hepatitis B virus surface antigen (HBsAg) using the yeast Pichia pastoris GS115 by inserting the HBsAg gene into the alcohol oxidase 1 locus. Results Large-scale production was optimized by developing a simple fed-batch process leading to enhanced product titers. Cells were first grown rapidly to high-cell density in a batch process using a simple defined medium with low salt and high glycerol concentrations. Induction of recombinant product synthesis was carried out using rather drastic conditions, namely through the addition of methanol to a final concentration of 6 g L-1. This methanol concentration was kept constant for the remainder of the cultivation through continuous methanol feeding based on the on-line signal of a flame ionization detector employed as methanol analyzer in the off-gas stream. Using this robust feeding protocol, maximum concentrations of ~7 grams HBsAg per liter culture broth were obtained. The amount of soluble HBsAg, competent for assembly into characteristic virus-like particles (VLPs), an attribute critical to its immunogenicity and efficacy as a hepatitis B vaccine, reached 2.3 grams per liter of culture broth. Conclusion In comparison to the highest yields reported so far, our simple cultivation process resulted in an ~7 fold enhancement in total HBsAg production with more than 30% of soluble protein competent for assembly into VLPs. This work opens up the possibility of significantly reducing the cost of vaccine production with implications for expanding hepatitis B vaccination in resource-poor countries.


Files in this item

Thumbnail
Name:
12934_2008_Article_333.pdf
Size:
850.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record